Showing results (1201-1210 of 2,524) with videos related to

Sort By:
Pageof 253
Inflammopharmacology|July 5, 2023
The orchestrating role of deteriorating neurons and TREM-1 in crosstalk with SYK in Alzheimer's disease progression and neuroinflammationMai M Anwar
Inflammopharmacology|July 5, 2023
Silver nanoparticles synthesized from Quercus brantii ameliorated ethanol-induced gastric ulcers in rats by decreasing oxidative stress and improving antioxidant systemsSaba Safari, Seifollah Bahramikia, Omid Dezfoulian
Inflammopharmacology|July 7, 2023
The association between neutrophil-to-lymphocyte ratio and disease activity in rheumatoid arthritisXiangsu Liu, Jiaqi Li, Leilei Sun, et al.
Inflammopharmacology|June 12, 2023
Postoperative analgesic efficacy and safety of imrecoxib versus celecoxib in hip osteoarthritis patients undergoing total hip arthroplasty: a multi-center, randomized, controlled, non-inferiority studyKai Zhang, Xiaoyan Miao, Liqiang Jiang, et al.
Inflammopharmacology|June 16, 2023
Emerging trends in combination strategies with phototherapy in advanced psoriasis managementRatnam Sreya, Shweta Nene, Vrushali Pathade, et al.
Inflammopharmacology|July 15, 2026
Nose-to-brain delivery of candesartan-loaded nanoemulsion: brain biodistribution and neurobehavioral outcomes in controlled cortical impact-induced traumatic brain injuryEtikala Amulya, Deepali Kumari, Tejaswini Kolipaka, et al.
Inflammopharmacology|April 21, 2018
β2-adrenoceptor signaling reduction is involved in the inflammatory response of fibroblast-like synoviocytes from adjuvant-induced arthritic ratsHuaxun Wu, Jingyu Chen, Chun Wang, et al.
Inflammopharmacology|July 18, 2019
Cysteinyl leukotriene receptor type 1 antagonist montelukast protects against injury of blood-brain barrierLi Zhou, Xiaomin Sun, Yong Shi, et al.
Inflammopharmacology|July 17, 2026
Resveratrol and neuroprotection: modulation of cellular dynamics and signaling networks in neurodegenerative diseasesMd Abul Hassan, Md Al Amin, Sherouk Hussein Sweilam, et al.
Inflammopharmacology|June 22, 2026
Canagliflozin attenuates Parkinson's disease and is associated with modulation of gut-inflammasome-brain axis in ratsNada K Gamal, Rafik Fakhry, Youmna Hatem, et al.
Pageof 253